Skip to main content
. 2022 Nov 23;14(12):2567. doi: 10.3390/pharmaceutics14122567

Table 1.

Kinetic study of IBU permeation through artificial membranes from the examined commercial formulations and from the developed nanogels based on EPIβCD in combination with CRP or HPMC prepared by emulsion-solvent evaporation (E.M.) or by conventional (C.M.) methods.

Formulation Zero-Order First-Order Higuchi Korsmeyer–Peppas
R2 R2 R2 R2 n
Lasonil 0.8138 0.8157 0.8988 0.9343 0.4
Vegetallumina 0.8517 0.8530 0.9869 0.9929 0.3
Dolofast 0.8708 0.8728 0.9413 0.9638 0.4
EPIβCD–CRP (E.M.) 0.9982 0.9985 0.9890 0.9985 0.6
EPIβCD–CRP (C.M.) 0.9936 0.9985 0.9890 0.9985 0.7
EPIβCD–HPMC (E.M.) 0.9933 0.9924 0.9771 0.9902 0.6